微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 36.91% | 5778.46% | -1.13% | 4/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | 37.33% | 3493.64% | 1142.74% | 2/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | -3.58% | -397.22% | 57.88% | 140/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | -8.5% | -1077.01% | -1207.69% | 121/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | -0.65% | -123.05% | 40.91% | 110/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -1.1% | -142.47% | -52.78% | 114/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -0.72% | -140% | -182.76% | 120/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 0.87% | -94.56% | -69.15% | 99/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 2.82% | -66.15% | 8.88% | 89/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.59% | -71.41% | 43.89% | 70/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.8% | -41.75% | -88.74% | 66/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 15.98% | -19.62% | 91.84% | 8/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.33% | -43.33% | -8.06% | 34/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 9.06% | -6.79% | 193.2% | 10/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.09% | -16.26% | -84.46% | 33/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 19.88% | 87.02% | 35.24% | 7/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 14.7% | 67.05% | 51.23% | 10/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 9.72% | 72.04% | 163.41% | 11/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.69% | 19.81% | -65.29% | 21/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 10.63% | 2.51% | 20.8% | 39/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 8.8% | -13.81% | 55.75% | 44/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.65% | -8.13% | 83.44% | 46/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.08% | 3.01% | -70.3% | 39/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 10.37% | -14.44% | 1.57% | 51/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 10.21% | -11.06% | 66.02% | 35/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 6.15% | -47.3% | 105.69% | 42/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 2.99% | -46.03% | -75.33% | 33/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 12.12% | -50.27% | 5.57% | 40/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 11.48% | 2% | -1.63% | 23/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 11.67% | -12.32% | 110.65% | 9/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 5.54% | 2% | -77.27% | 10/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 24.37% | -14.61% | 83.1% | 6/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 13.31% | -22.62% | -53.36% | 4/159 | 4.62% | 奥赛康 | 40.69% | 行业排名> |
| 2017-12-31 | 28.54% | -8.29% | 65.93% | 2/159 | 9.61% | 信立泰 | 25.93% | 行业排名> |
| 2017-06-30 | 17.2% | 2% | -44.73% | 2/159 | 5.55% | 昂利康 | 15.91% | 行业排名> |
| 2016-12-31 | 31.12% | 58.45% | 58.45% | 4/159 | 6.11% | 奥赛康 | 12.08% | 行业排名> |